Selected research
Industry Research
Colonoscopy Bowel Preparation Drugs Industry Research Report 2026
Market perspective
The global Colonoscopy Bowel Preparation Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Colonoscopy Bowel Preparation Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Colonoscopy Bowel Preparation Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Colonoscopy Bowel Preparation Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Colonoscopy Bowel Preparation Drugs include Bausch Health Companies, Braintree, Ferring, Norgine BV and Bayer AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Colonoscopy Bowel Preparation Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Colonoscopy Bowel Preparation Drugs Market by Company
Bausch Health Companies
Braintree
Ferring
Norgine BV
Bayer AG
Colonoscopy Bowel Preparation Drugs Segment by Type
Combination Agents
Hyposmotic Agents
Hyperosmotic Agents
Isosmotic Agents
Colonoscopy Bowel Preparation Drugs Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
Colonoscopy Bowel Preparation Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colonoscopy Bowel Preparation Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colonoscopy Bowel Preparation Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colonoscopy Bowel Preparation Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Colonoscopy Bowel Preparation Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Colonoscopy Bowel Preparation Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Colonoscopy Bowel Preparation Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Combination Agents
- Hyposmotic Agents
- Hyperosmotic Agents
- Isosmotic Agents
Applications
- Hospital Pharmacies
- Retail Pharmacies
- Others
Companies covered
- Bausch Health Companies
- Braintree
- Ferring
- Norgine BV
- Bayer AG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Colonoscopy Bowel Preparation Drugs Market Size (2021-2032)
- 2.2.2 Global Colonoscopy Bowel Preparation Drugs Sales (2021-2032)
- 2.2.3 Global Colonoscopy Bowel Preparation Drugs Market Average Price (2021-2032)
- 2.3 Colonoscopy Bowel Preparation Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Combination Agents
- 2.3.3 Hyposmotic Agents
- 2.3.4 Hyperosmotic Agents
- 2.3.5 Isosmotic Agents
- 2.4 Colonoscopy Bowel Preparation Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Retail Pharmacies
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Colonoscopy Bowel Preparation Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Colonoscopy Bowel Preparation Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Colonoscopy Bowel Preparation Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Colonoscopy Bowel Preparation Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Colonoscopy Bowel Preparation Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Colonoscopy Bowel Preparation Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Colonoscopy Bowel Preparation Drugs, Product Type & Application
- 3.8 Global Manufacturers of Colonoscopy Bowel Preparation Drugs, Established Date
- 3.9 Global Colonoscopy Bowel Preparation Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bausch Health Companies
- 4.1.1 Bausch Health Companies Company Information
- 4.1.2 Bausch Health Companies Business Overview
- 4.1.3 Bausch Health Companies Colonoscopy Bowel Preparation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bausch Health Companies Colonoscopy Bowel Preparation Drugs Product Portfolio
- 4.1.5 Bausch Health Companies Recent Developments
- 4.2 Braintree
- 4.2.1 Braintree Company Information
- 4.2.2 Braintree Business Overview
- 4.2.3 Braintree Colonoscopy Bowel Preparation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Braintree Colonoscopy Bowel Preparation Drugs Product Portfolio
- 4.2.5 Braintree Recent Developments
- 4.3 Ferring
- 4.3.1 Ferring Company Information
- 4.3.2 Ferring Business Overview
- 4.3.3 Ferring Colonoscopy Bowel Preparation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ferring Colonoscopy Bowel Preparation Drugs Product Portfolio
- 4.3.5 Ferring Recent Developments
- 4.4 Norgine BV
- 4.4.1 Norgine BV Company Information
- 4.4.2 Norgine BV Business Overview
- 4.4.3 Norgine BV Colonoscopy Bowel Preparation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Norgine BV Colonoscopy Bowel Preparation Drugs Product Portfolio
- 4.4.5 Norgine BV Recent Developments
- 4.5 Bayer AG
- 4.5.1 Bayer AG Company Information
- 4.5.2 Bayer AG Business Overview
- 4.5.3 Bayer AG Colonoscopy Bowel Preparation Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bayer AG Colonoscopy Bowel Preparation Drugs Product Portfolio
- 4.5.5 Bayer AG Recent Developments
5 Global Colonoscopy Bowel Preparation Drugs Market Scenario by Region
- 5.1 Global Colonoscopy Bowel Preparation Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Colonoscopy Bowel Preparation Drugs Sales by Region: 2021-2032
- 5.2.1 Global Colonoscopy Bowel Preparation Drugs Sales by Region: 2021-2026
- 5.2.2 Global Colonoscopy Bowel Preparation Drugs Sales by Region: 2027-2032
- 5.3 Global Colonoscopy Bowel Preparation Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Colonoscopy Bowel Preparation Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Colonoscopy Bowel Preparation Drugs Revenue by Region: 2027-2032
- 5.4 North America Colonoscopy Bowel Preparation Drugs Market Facts & Figures by Country
- 5.4.1 North America Colonoscopy Bowel Preparation Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Colonoscopy Bowel Preparation Drugs Sales by Country (2021-2032)
- 5.4.3 North America Colonoscopy Bowel Preparation Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Colonoscopy Bowel Preparation Drugs Market Facts & Figures by Country
- 5.5.1 Europe Colonoscopy Bowel Preparation Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Colonoscopy Bowel Preparation Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Colonoscopy Bowel Preparation Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Colonoscopy Bowel Preparation Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Colonoscopy Bowel Preparation Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Colonoscopy Bowel Preparation Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Colonoscopy Bowel Preparation Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Colonoscopy Bowel Preparation Drugs Market Facts & Figures by Country
- 5.7.1 South America Colonoscopy Bowel Preparation Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Colonoscopy Bowel Preparation Drugs Sales by Country (2021-2032)
- 5.7.3 South America Colonoscopy Bowel Preparation Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Colonoscopy Bowel Preparation Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Colonoscopy Bowel Preparation Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Colonoscopy Bowel Preparation Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Colonoscopy Bowel Preparation Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Colonoscopy Bowel Preparation Drugs Sales by Type (2021-2032)
- 6.1.1 Global Colonoscopy Bowel Preparation Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Colonoscopy Bowel Preparation Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Colonoscopy Bowel Preparation Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Colonoscopy Bowel Preparation Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Colonoscopy Bowel Preparation Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Colonoscopy Bowel Preparation Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Colonoscopy Bowel Preparation Drugs Sales by Application (2021-2032)
- 7.1.1 Global Colonoscopy Bowel Preparation Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Colonoscopy Bowel Preparation Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Colonoscopy Bowel Preparation Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Colonoscopy Bowel Preparation Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Colonoscopy Bowel Preparation Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Colonoscopy Bowel Preparation Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Colonoscopy Bowel Preparation Drugs Value Chain Analysis
- 8.1.1 Colonoscopy Bowel Preparation Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Colonoscopy Bowel Preparation Drugs Production Mode & Process
- 8.2 Colonoscopy Bowel Preparation Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Colonoscopy Bowel Preparation Drugs Distributors
- 8.2.3 Colonoscopy Bowel Preparation Drugs Customers
9 Global Colonoscopy Bowel Preparation Drugs Analyzing Market Dynamics
- 9.1 Colonoscopy Bowel Preparation Drugs Industry Trends
- 9.2 Colonoscopy Bowel Preparation Drugs Industry Drivers
- 9.3 Colonoscopy Bowel Preparation Drugs Industry Opportunities and Challenges
- 9.4 Colonoscopy Bowel Preparation Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst